Growth Metrics

Invivyd (IVVD) Current Leases (2022 - 2025)

Invivyd posted quarterly Current Leases of $1.3 million for Q4 2025, up 0.77% year-on-year from $1.3 million in Q4 2024, and up 19.45% on a QoQ basis from $1.1 million in Q3 2025.

Invivyd (IVVD) has 4 years of Current Leases data on file, last reported at $1.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 0.77% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (up 0.77% YoY), and the FY2025 full-year result was $1.3 million, up 0.77% from the prior year.
  • Current Leases for Q4 2025 stood at $1.3 million, up from $1.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q3 2023 and bottomed at $315000.0 in Q1 2022.
  • The 4-year median for Current Leases is $1.2 million (2024), against an average of $1.1 million.
  • The widest annual swing landed in 2023, when Current Leases jumped 403.17%; it then tumbled 57.73% in 2024.
  • A 4-year view of Current Leases shows it stood at $1.6 million in 2022, then fell by 7.44% to $1.4 million in 2023, then decreased by 9.63% to $1.3 million in 2024, then rose by 0.77% to $1.3 million in 2025.
  • The last three Current Leases figures came in at $1.3 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 1.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 900,000.00
Dec 31, 2024 1.30 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 681,000.00
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.44 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 1.59 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 329,000.00
Jun 30, 2022 969,000.00
Mar 31, 2022 315,000.00